DE122008000001I1 - Orale Dosiszusammensetzungen mit verlängerter Freigabe - Google Patents

Orale Dosiszusammensetzungen mit verlängerter Freigabe

Info

Publication number
DE122008000001I1
DE122008000001I1 DE122008000001C DE122008000001C DE122008000001I1 DE 122008000001 I1 DE122008000001 I1 DE 122008000001I1 DE 122008000001 C DE122008000001 C DE 122008000001C DE 122008000001 C DE122008000001 C DE 122008000001C DE 122008000001 I1 DE122008000001 I1 DE 122008000001I1
Authority
DE
Germany
Prior art keywords
release dosage
prolonged release
dosage compositions
oral prolonged
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE122008000001C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Merck Sharp and Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US17275299P priority Critical
Application filed by Merck Sharp and Dohme Corp filed Critical Merck Sharp and Dohme Corp
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122008000001(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of DE122008000001I1 publication Critical patent/DE122008000001I1/de
Application status is Pending legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
DE122008000001C 1999-12-20 2000-12-20 Orale Dosiszusammensetzungen mit verlängerter Freigabe Pending DE122008000001I1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17275299P true 1999-12-20 1999-12-20

Publications (1)

Publication Number Publication Date
DE122008000001I1 true DE122008000001I1 (de) 2008-04-17

Family

ID=22629073

Family Applications (3)

Application Number Title Priority Date Filing Date
DE60028710T Active DE60028710T2 (de) 1999-12-20 2000-12-20 Orale Dosiszusammensetzung mit verlängerter Freigabe
DE60042904A Active DE60042904D1 (de) 1999-12-20 2000-12-20 Orale Dosiszusammensetzung mit verlängerter Freigabe
DE122008000001C Pending DE122008000001I1 (de) 1999-12-20 2000-12-20 Orale Dosiszusammensetzungen mit verlängerter Freigabe

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE60028710T Active DE60028710T2 (de) 1999-12-20 2000-12-20 Orale Dosiszusammensetzung mit verlängerter Freigabe
DE60042904A Active DE60042904D1 (de) 1999-12-20 2000-12-20 Orale Dosiszusammensetzung mit verlängerter Freigabe

Country Status (38)

Country Link
US (3) US6709676B2 (de)
EP (3) EP2100600A1 (de)
JP (2) JP5158919B2 (de)
KR (2) KR20010062543A (de)
CN (3) CN100415223C (de)
AR (1) AR027034A1 (de)
AT (2) AT329584T (de)
AU (2) AU2276801A (de)
BR (1) BR0005938A (de)
CA (1) CA2329172C (de)
CO (1) CO5251421A1 (de)
CY (1) CY1109636T1 (de)
CZ (1) CZ302471B6 (de)
DE (3) DE60028710T2 (de)
DK (2) DK1110543T3 (de)
EC (1) ECSP003835A (de)
ES (2) ES2261158T3 (de)
HK (2) HK1034452A1 (de)
HU (1) HU227538B1 (de)
IL (1) IL140451A (de)
LU (1) LU91403I2 (de)
MX (1) MXPA00012957A (de)
MY (1) MY128658A (de)
NL (1) NL300328I2 (de)
NO (1) NO331653B1 (de)
NZ (1) NZ509034A (de)
PE (1) PE20010952A1 (de)
PL (1) PL209401B1 (de)
PT (2) PT1674084E (de)
RU (1) RU2284182C9 (de)
SA (2) SA2362B1 (de)
SG (2) SG183573A1 (de)
SI (2) SI1110543T1 (de)
SK (1) SK287105B6 (de)
TR (1) TR200003788A2 (de)
TW (1) TWI222885B (de)
WO (1) WO2001045676A2 (de)
ZA (1) ZA200007714B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
JP2009132734A (ja) * 2001-08-27 2009-06-18 Daiichi Sankyo Healthcare Co Ltd 抗感冒剤
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
CL2003002653A1 (es) * 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
EP1507774A1 (de) * 2003-03-12 2005-02-23 Biogal Gyogyszergyar Rt. Verfahren zur herstellung von polymorphen formen von desloratadin
WO2005046650A1 (en) * 2003-11-12 2005-05-26 Glenmark Pharmaceuticals Limited Pharmaceutical formulation containing muscle relaxant and cox-ii inhibitor
EP1696881A2 (de) * 2003-12-23 2006-09-06 Sun Pharmaceutical Industries Limited Stabile orale zusammensetzung
WO2006095819A1 (ja) * 2005-03-10 2006-09-14 Taisho Pharmaceutical Co., Ltd. 糖衣剤
US20110081415A1 (en) * 2005-03-10 2011-04-07 Taisho Pharmaceutical Co., Ltd Coating apparatus
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20070004671A1 (en) * 2005-05-20 2007-01-04 Agarwal Sudeep K Stable desloratadine compositions
EP1728513A3 (de) * 2005-05-20 2007-10-31 Dr. Reddy's Laboratories, Inc. Stabile Zusammensetzungen von Desloratadine
US20070014855A1 (en) * 2005-07-12 2007-01-18 Rahul Gawande S Stable desloratadine compositions
ZA200801158B (en) 2005-09-09 2009-08-26 Labopharm Inc Sustained drug release composition
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US20070124218A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
WO2007096733A2 (en) * 2006-02-22 2007-08-30 Orchid Chemicals & Pharmaceuticals Limited Desloratadine-containing formulation stabilized with cyclodextrin
CA2541045A1 (en) * 2006-03-24 2007-09-24 Pharmascience Inc. A descarbonylethoxyloratadine containing pharmaceutical composition
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
MX2008015357A (es) * 2006-06-01 2009-03-06 Schering Corp Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas.
AU2007254821B2 (en) 2006-06-01 2013-11-14 Bayer Consumer Care Ag Sustained release pharmaceutical formulation comprising phenylephrine
PE20150773A1 (es) * 2006-06-01 2015-05-21 Merck Sharp & Dohme Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US7718649B1 (en) * 2006-11-10 2010-05-18 Pisgah Labs, Inc. Physical states of a pharmaceutical drug substance
BRPI0812784A2 (pt) * 2007-06-01 2014-12-02 Schering Plough Healthcare Composição farmacêutica compreendendo um substrato e um revestimento contendo um ingrediente ativo e polivinilálcool
TWI400042B (zh) * 2007-06-08 2013-07-01 Tci Co Ltd 食品錠劑
WO2009049405A1 (en) 2007-10-16 2009-04-23 Labopharm Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
CN101969930A (zh) 2007-12-17 2011-02-09 莱博法姆公司;莱博法姆欧洲有限公司;莱博法姆(巴巴多斯)有限公司 防滥用控制释放制剂
US8486449B2 (en) 2008-12-16 2013-07-16 Paladin Labs Inc. Misuse preventative, controlled release formulation
JP6047149B2 (ja) 2011-05-04 2016-12-21 インテリカイン, エルエルシー 併用の医薬組成物およびその使用
BR102012030828A2 (pt) 2012-12-03 2014-09-16 Ems Sa Composição farmacêutica compreendendo desloratadina e prednisolona e seu uso
US10463656B2 (en) 2017-01-05 2019-11-05 Iowa State University Research Foundation, Inc. Methods and compositions for prevention of feedlot bovine respiratory disease
CN108578406A (zh) * 2018-04-18 2018-09-28 曹建华 一种用于过敏性鼻炎治疗的组合物

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3940485A (en) 1973-12-12 1976-02-24 Levinson Harold N Treatment and pre-treatment of dysmetric dyslexia by improving sequential scanning and ocular fixation abilities and therapeutic compounds
US4008796A (en) 1974-03-26 1977-02-22 General Concrete Of Canada Limited Control method for feeding items on a conveyor
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4282233B1 (en) 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
AU570306B2 (en) 1984-02-15 1988-03-10 Schering Corporation 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899B1 (de) 1984-04-09 1992-10-20 Analgesic Associates
SE8404467D0 (sv) 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
US4731447A (en) 1985-05-13 1988-03-15 Schering Corporation Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof
US4804666A (en) 1985-08-14 1989-02-14 Schering Corporation Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
JPS6396126A (en) 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd Stabilized composition
US5089496A (en) 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4777170A (en) 1987-02-03 1988-10-11 Heinrich William A Method to prevent and treat the signs and symptoms of motion sickness
GB8707421D0 (en) 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US4863931A (en) 1988-09-15 1989-09-05 Schering Corporation Antihistaminic fluoro substituted benzocycloheptapyridines
US5019591A (en) 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
US4990535A (en) 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
ZA9104764B (en) 1990-06-22 1992-03-25 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene,piperidylidene and piperazine compounds,compositions and methods of use
US5416091A (en) 1990-12-18 1995-05-16 Burroughs Wellcome Co. Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
MX9202350A (es) 1991-05-20 1992-11-01 Alza Corp Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
US5314697A (en) 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
JP2646972B2 (ja) 1993-11-01 1997-08-27 日本電気株式会社 多ビットメモリ
DE4442999A1 (de) 1994-12-02 1996-06-05 Hexal Pharma Gmbh Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US7211582B1 (en) * 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
US7214683B1 (en) * 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
WO1998018470A1 (en) 1996-10-31 1998-05-07 Schering Corporation Composition, for the treatment of asthma, containing loratadine and a decongestant
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
US5900421A (en) 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
US5939426A (en) 1997-02-28 1999-08-17 Sepracor Inc. Methods for treating urinary incontinence using descarboethoxyloratadine
US6506767B1 (en) 1997-07-02 2003-01-14 Schering Corporation 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
ID22891A (id) * 1997-08-26 1999-12-16 Hoechst Marion Roussel Inc Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
US6270796B1 (en) 1997-10-29 2001-08-07 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
BR9910449A (pt) * 1998-07-10 2001-01-02 Schering Corp Composições orais de 8-cloro-6,11-diidro-11-(4-piperidilideno)-5h-benzo[5,6]c icloepta[1,2-b]piridina
US6423721B1 (en) * 1998-09-10 2002-07-23 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6051585A (en) 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6100274A (en) 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
WO2001045676A2 (en) 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
BR0107960A (pt) * 2000-02-03 2002-10-29 Schering Corp Tratamento de condições alérgicas e inflamatórias
MXPA02011480A (es) * 2000-05-19 2003-06-06 Alcon Inc Derivados de disulfuro de anilina para tratar enfermedades alergicas.
US6599913B1 (en) 2001-06-29 2003-07-29 Schering Corporation Treating allergic and inflammatory conditions
US6679463B1 (en) * 2003-06-11 2004-01-20 Kye Systems Corp. Support with multi-stage clamping mechanism
EP1696881A2 (de) * 2003-12-23 2006-09-06 Sun Pharmaceutical Industries Limited Stabile orale zusammensetzung
ZA200701036B (en) * 2004-07-16 2008-05-28 Cipla Ltd Anti-histaminic composition

Also Published As

Publication number Publication date
CA2329172A1 (en) 2001-06-20
IL140451A (en) 2011-11-30
AT329584T (de) 2006-07-15
KR20080044214A (ko) 2008-05-20
NO20006503L (no) 2001-06-21
HK1090840A1 (en) 2009-12-31
HU0004989A3 (en) 2008-04-28
WO2001045676A3 (en) 2002-01-03
SI1674084T1 (sl) 2010-01-29
RU2284182C2 (ru) 2006-09-27
EP1110543B1 (de) 2006-06-14
EP1110543A2 (de) 2001-06-27
MXPA00012957A (es) 2003-06-19
AU777419B2 (en) 2004-10-14
CN101322708A (zh) 2008-12-17
KR20010062543A (ko) 2001-07-07
CZ20004813A3 (cs) 2001-08-15
BR0005938A (pt) 2001-11-27
SK287105B6 (sk) 2009-12-07
CN1302605A (zh) 2001-07-11
NO331653B1 (no) 2012-02-13
US6709676B2 (en) 2004-03-23
PT1674084E (pt) 2009-10-19
EP1674084B1 (de) 2009-09-02
CY1109636T1 (xx) 2014-08-13
TWI222885B (en) 2004-11-01
NL300328I2 (nl) 2008-07-01
AR027034A1 (es) 2003-03-12
EP1110543A3 (de) 2001-08-29
PT1110543E (pt) 2006-08-31
NL300328I1 (nl) 2008-03-03
CN101134038A (zh) 2008-03-05
US7618649B2 (en) 2009-11-17
AU7244200A (en) 2001-06-21
CO5251421A1 (es) 2003-02-28
SG183573A1 (en) 2012-09-27
JP5158919B2 (ja) 2013-03-06
NO20006503D0 (no) 2000-12-20
DK1110543T3 (da) 2006-09-18
CZ302471B6 (cs) 2011-06-08
SK19662000A3 (sk) 2001-09-11
DK1674084T3 (da) 2009-12-14
US20100021542A1 (en) 2010-01-28
DE60042904D1 (de) 2009-10-15
HK1034452A1 (en) 2006-09-08
MY128658A (en) 2007-02-28
ES2261158T3 (es) 2006-11-16
JP2008081509A (ja) 2008-04-10
RU2284182C9 (ru) 2007-11-20
EP1674084A3 (de) 2006-07-05
JP2001206846A (ja) 2001-07-31
AT441404T (de) 2009-09-15
DE60028710T2 (de) 2007-06-14
CN101134038B (zh) 2013-11-06
DE60028710D1 (de) 2006-07-27
US20030031713A1 (en) 2003-02-13
SI1110543T1 (sl) 2006-10-31
HU0004989A2 (hu) 2004-05-28
PE20010952A1 (es) 2001-09-25
PL209401B1 (xx) 2011-08-31
US8187630B2 (en) 2012-05-29
SA2362B1 (ar) 2009-12-23
SG149667A1 (en) 2009-02-27
WO2001045676A2 (en) 2001-06-28
EP2100600A1 (de) 2009-09-16
HU227538B1 (en) 2011-08-29
AU2276801A (en) 2001-07-03
EP1674084A2 (de) 2006-06-28
TR200003788A2 (tr) 2001-07-23
ES2330873T3 (es) 2009-12-16
PL344714A1 (en) 2001-07-02
NZ509034A (en) 2002-09-27
HU0004989D0 (de) 2001-02-28
IL140451D0 (en) 2002-02-10
SA01210740A (ar) 2005-12-03
LU91403A9 (de)
LU91403I2 (fr) 2008-02-21
SA1490B1 (ar) 2006-10-31
ZA200007714B (en) 2001-08-16
TR200003788A3 (tr) 2001-07-23
ECSP003835A (es) 2002-02-25
US20040097536A1 (en) 2004-05-20
CN100415223C (zh) 2008-09-03
CA2329172C (en) 2005-10-25

Similar Documents

Publication Publication Date Title
DE69807756D1 (de) Fotopolymerisierbare dentalzusammensetzungen
DE60005994D1 (de) Verflüssigbare pulverzusammensetzungen
DE60229745D1 (de) Mundpflegezusammensetzungen
DE69932158D1 (de) Pharmazeutische zusammenstellungen
DE60215148D1 (de) Mundpflegezusammensetzungen
FR2795324B1 (fr) Compositions pharmaceutiques stabilisees
DE60106623D1 (de) Neue pharmazeutische zusammensetzung
DE69819205D1 (de) Orale pharmazeutische dosierungsform beruhend auf stossweiser freisetzung
DK1333799T3 (da) Oral sammensætning til forbedret fjernelse af misfarvning fra tænder
DK1043976T3 (da) Oral farmaceutisk doseringsform med langvarig frigivelse
DE60045324D1 (de) Impfstoffzusammensetzung
DK1318788T3 (da) Nanopartikulær fastdosissammensætninger
DK1140088T3 (da) Orale methylphenidatformuleringer med reguleret/modificeret frigivelse
DE60016903D1 (de) Antiperspirant-zusammensetzungen
DE69942205D1 (de) Microemulsionen als feste dosisformen zur oralen verabreichung
DE60038698D1 (de) Hydrogel-gesteuerte dosierungsform
DE60044819D1 (de) Orale zusammensetzungen enthaltend zinn-ionen
DE60027029D1 (de) Kombinierte impfstoffzusammensetzungen
DE69833157D1 (de) Stabile orale pharmazeutische Zusammensetzung enthaltend ein Pyridylsulfinyl-substituiertes Benzimidazole
DE60017545D1 (de) Opaleszierende füllstoffe für dentale restorationszusammensetzungen
DE60004325D1 (de) Hypoallergene zubereitung enthaltend tolerogene petide, zur induzierung oraler toleranz
DE60142197D1 (de) Pharmazeutische Zusammensetzung
DE60109207D1 (de) Orale zusammensetzung
DE60140945D1 (de) Östrogene mittel enthaltende arzneizusammensetzungen
DE60131703D1 (de) Orale feste pharmazeutische Zusammensetzungen zur pH-abhängig mehrphasigen Freisetzung